Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas
Objectives: Endometrial stromal sarcomas (ESS) are rare, accounting for < 1% of all uterine malignancies. Treatment has been guided by small case series and retrospective studies. Endocrine therapy is used in both adjuvant and metastatic settings. Aromatase inhibitors (AIs) are widely used in cli...
Saved in:
Main Authors: | Fionnuala Crowley (Author), Karen A. Cadoo (Author), Sarah Chiang (Author), Diana L. Mandelker (Author), Raazi Bajwa (Author), Alexia Iasonos (Author), Qin C. Zhou (Author), Kathryn M. Miller (Author), Martee L. Hensley (Author), Roisin E. O'Cearbhaill (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of romiplostim for antineoplastic therapy-induced thrombocytopenia in gynecologic and breast cancers
by: Sara Moufarrij, et al.
Published: (2024) -
Extrauterine Low-Grade Endometrial Stromal Sarcoma
by: Yu-Ju Chen, et al.
Published: (2005) -
Immunohistochemical and Molecular Characterization of Endometrial Stromal Sarcomas
by: Sneha Subbaraya, et al.
Published: (2020) -
Primary low-grade endometrial stromal sarcoma of the omentum
by: Kiran Clair, et al.
Published: (2017) -
Vaginal endometrial stromal sarcoma: A literature review
by: Hongwen Wu, et al.
Published: (2019)